- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Home chemotherapy
My oncology training was undertaken at St. Bartholomew’s, UCLH and Mount Vernon Hospitals. Following my Fellowship, I undertook a postgraduate research degree at Imperial College School of Medicine, Hammersmith Hospital. There I investigated the potential for Positron Emission Tomography (PET) to demonstrate the biological effects of chemotherapy in tissue.
I have published a number of papers in this area and was awarded a PhD for my work. Subsequently I completed my post doctoral training at the Royal Marsden Hospital, principally with the Academic Urology Unit.
I specialise in the management of patients with genitourinary (bladder and prostate) and thoracic (lung and mesothelioma) malignancies. Furthermore I have significant expertise in the delivery of real time dynamic prostate low dose rate (LDR) brachytherapy for patients with early stage, localised prostate cancer. I am also a registered Cyberknife practitioner with a National referral practice and deliver stereotactic radiotherapy (SABR) in both the radical and palliative (for metastatic disease) setting.
Since taking up my present post I have been extensively involved with the development of the genitourinary and thoracic cancer services for the North East London Cancer Network and London Cancer.
I am an active participant in UK clinical trials and am principal investigator for the North East London Cancer Network for a number of studies. I introduced Intensity Modulated (IMRT) and image guided (IGRT) radiotherapy to my NHS practice in 2010, which was mirrored in my private work. I have significant experience in chemo-radiation in bladder and lung cancer and stereotactic radiotherapy for lung and prostate cancer in the radical setting and the treatment of oligometastatic disease for all tumour sites including brain. My research interest in PET continues to develop with an emphasis on investigating the direct effects of radiotherapy on tissue and the effect of integration of novel therapies with radiation.
Areas of interest
• Bladder Cancer • Prostate Cancer • Mesothelioma • Lung cancer • Cyberknife • Prostate brachytherapy; chemotherapy; targeted therapy; immunotherapy
Current NHS consultant posts held
Consultant Clinical Oncologist
St Bartholomews Hospital, West Smithfield, London EC1A 7BE
Homerton Hospital, Hackney London E9 6SR
WhippsCross Hospital, Leytonstone, London E11 1NR
Advanced radiotherapy techniques including Cyberknife.
Clinical trials in GU malignancy and Lung cancer/mesothelioma.
Rohan Williams Medal Clinical Oncology 1994
British Oncological Association Young Investigator Award 1996
European Society for Therapeutic Radiation Oncology Travel Award 1996
Winner of Royal College of Radiologists national competition for Glaxo Wellcome Fellowship 1996
American Society Clinical Oncology Merit Award 1997
Cancer Research Campaign Clinical Research Fellowship 2000
- MRCP Royal College of Physicians 1989
- PhD Imperial College London 2001
- FRCR Royal College of Radiologists 1994
Reference number 3120550
- The London Oncology Clinic LLP, 96 Harley...
- 09:30 - 17:00
- 020 7034 8689
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)
Peripherally inserted central venous catheters (PICCs) under x-ray guidance - (1-5)
Harley Street Clinic (1-5)